Literature DB >> 30950056

The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy.

Mohsen Alizadeh1, Ali Safarzadeh1, Fatemeh Beyranvand2, Fatemeh Ahmadpour3, Khalil Hajiasgharzadeh1, Amir Baghbanzadeh1, Behzad Baradaran1.   

Abstract

miR-29 family is one of the small noncoding RNAs and has a very important role in many physiologic and pathologic functions through regulating the target genes that play roles in various bioprocesses such as proliferation, survival, apoptosis, and angiogenesis. Thus, we aim to survey the potential of the miR-29 family in normal model and development and progression of malignancy in this study. In addition, the potential role of miR-29 family has been studied as the clinical marker for the diagnosis and prognosis of many cancers as the potential targets to treat cancer. Moreover, it was stated in summary that the herbal compounds can regulate miR-29 family in cancers. Therefore, regulating the expression of the miR-29 family in a variety of cancers can be a new strategy to obtain better results from cancerous patients' treatment in the future.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer treatment; herbal compounds; malignancy; miR-29 family

Mesh:

Substances:

Year:  2019        PMID: 30950056     DOI: 10.1002/jcp.28607

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  20 in total

1.  Joint detection of miR-149-3p and hepcidin predicts the onset of obstructive sleep apnea syndrome in obese patients.

Authors:  Lina Xu; Haipeng Gao; Weizhen Wang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-08-03

2.  miR-29a in Exosomes from Bone Marrow Mesenchymal Stem Cells Inhibit Fibrosis during Endometrial Repair of Intrauterine Adhesion.

Authors:  Qingqing Tan; Dandan Xia; Xiaoyan Ying
Journal:  Int J Stem Cells       Date:  2020-11-30       Impact factor: 2.500

Review 3.  Role of the microRNA-29 family in myocardial fibrosis.

Authors:  Changyan Li; Nan Wang; Peng Rao; Limeiting Wang; Di Lu; Lin Sun
Journal:  J Physiol Biochem       Date:  2021-05-28       Impact factor: 4.158

4.  Expression and clinical significance of miR-338 and miR-20a in serum of patients with gastric carcinoma.

Authors:  Min Li; Jueping Feng; Chang Gao; Wen Sun; Yilian Chen
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.

Authors:  Hideyuki Ohzawa; Akira Saito; Yuko Kumagai; Yuki Kimura; Hironori Yamaguchi; Yoshinori Hosoya; Alan Kawarai Lefor; Naohiro Sata; Joji Kitayama
Journal:  Oncol Rep       Date:  2020-02-17       Impact factor: 3.906

Review 6.  The Epigenetic Landscape of Vascular Calcification: An Integrative Perspective.

Authors:  Yi-Chou Hou; Chien-Lin Lu; Tzu-Hang Yuan; Min-Tser Liao; Chia-Ter Chao; Kuo-Cheng Lu
Journal:  Int J Mol Sci       Date:  2020-02-01       Impact factor: 5.923

Review 7.  From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis.

Authors:  Raphael Mohr; Burcin Özdirik; Joeri Lambrecht; Münevver Demir; Johannes Eschrich; Lukas Geisler; Teresa Hellberg; Sven H Loosen; Tom Luedde; Frank Tacke; Linda Hammerich; Christoph Roderburg
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

8.  MicroRNA‑29a promotes the neural differentiation of rat neural stem/progenitor cells by targeting KLF4.

Authors:  Yunan Gao; Hu Qiao; Tianyu Zhong; Zhen Lu; Yuxia Hou
Journal:  Mol Med Rep       Date:  2020-05-22       Impact factor: 2.952

9.  MiR-29b-3p promotes particulate matter-induced inflammatory responses by regulating the C1QTNF6/AMPK pathway.

Authors:  Jian Wang; Mengchan Zhu; Ling Ye; Cuicui Chen; Jun She; Yuanlin Song
Journal:  Aging (Albany NY)       Date:  2020-01-18       Impact factor: 5.682

10.  Circulating miR-21, miR-29a, and miR-126 are associated with premature death risk due to cancer and cardiovascular disease: the JACC Study.

Authors:  Hiroya Yamada; Koji Suzuki; Ryosuke Fujii; Miyuki Kawado; Shuji Hashimoto; Yoshiyuki Watanabe; Hiroyasu Iso; Yoshihisa Fujino; Kenji Wakai; Akiko Tamakoshi
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.